Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This should be a clean, draft-free area
This preserves muscle mass and maintains metabolic rate during your cut
Obviously well have to watch for this in the phase 3 Eloralintide trials as well, but given its highly selective activity on Amylin receptors and lack of engagement on the calcitonin receptor, it may not develop into an issue at the doses Lilly is testing
References Frontiers in Endocrinology (2021) Progress on the Function and Application of Thymosin 4 Annals of the New York Academy of Sciences Thymosin 4: roles in development, repair, and engineering of the cardiovascular system Frontiers in Pharmacology (2022) Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 HSS Journal (2025) Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Current Pharmaceutical Design (2018) Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract Journal of Orthopaedic Surgery and Research (2019) BPC 157 and its effects on tendon healing CDC (2024) Vaccine Administration: Subcutaneous (SUBCUT) Injection NCBI Bookshelf (2023) Administration of Parenteral Medications Nursing Skills CDC (NCHS) Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
GLP-1 peptides are strictly contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
